Oracle Shares Slump as Market Skepticism Overrides AI Partnership Denials

Despite issuing firm denials regarding reported delays in its high-profile artificial intelligence infrastructure collaboration, Oracle Corporation saw its stock decline sharply on Monday. The shares closed down 2.7% at $184.79, extending a losing streak that has now erased approximately 15% of their value since the company’s disappointing quarterly earnings report last week. This persistent sell-off raises pressing questions among investors about the credibility of Oracle’s ambitious AI-driven growth narrative.

Earnings Report Sets the Stage for Concern

The current wave of investor apprehension was triggered by Oracle’s fiscal second-quarter results, released on December 10th. The figures presented a mixed picture:

• Non-GAAP Earnings Per Share: $2.26, significantly surpassing estimates of $1.64.
• Total Revenue: $16.06 billion, slightly missing the consensus forecast of $16.19 billion.
• Cloud Revenue: $8.0 billion, representing a 34% year-over-year increase.

A standout figure was the record-breaking Remaining Performance Obligations (RPO), which surged 15% sequentially to $523 billion. While indicative of strong future demand, this massive backlog necessitates substantial upfront capital expenditure. Oracle subsequently announced a dramatic $15 billion increase in its capital investment plan for fiscal 2026, pushing the company’s total debt load above $100 billion. This aggressive spending commitment has directly pressured free cash flow and fueled market worries over potential margin erosion.

Partnership Rumors Meet Official Rebuttal

Adding to the negative sentiment, a Bloomberg report suggested that Oracle had pushed back the completion timeline for key data centers central to its multi-billion-dollar partnership with OpenAI from 2027 to 2028. This infrastructure is part of a broader collaboration reportedly valued at $300 billion.

Should investors sell immediately? Or is it worth buying Oracle?

Oracle moved to counter these claims on Monday afternoon. The company stated that all project milestones remain on schedule, emphasizing that site selection and delivery timelines were established jointly with OpenAI. It firmly denied any delays related to its contractual obligations.

The market’s reaction was unequivocal. Investors largely dismissed the clarification, with the stock trading a high volume of 43.6 million shares and closing near its daily low. The skepticism appears deeply rooted in concerns over the company’s escalating investment costs.

Analysts Recalibrate Expectations

In tandem with the stock’s decline, several equity research firms adjusted their outlooks. Analysts at Sanford C. Bernstein lowered their price target on Oracle from $364 to $339, while maintaining an “Outperform” rating. Similarly, KeyCorp reduced its target from $350 to $300, though it kept an “Overweight” recommendation. The consensus message from analysts is that while the long-term AI opportunity remains intact, near-term valuation models must account for the significantly higher expenditure profile.

A Critical Juncture for Investor Confidence

Oracle’s stock is currently testing a key support zone between $180 and $185. A decisive break below this level could signal further consolidation ahead. The immediate future hinges on Oracle’s ability to demonstrate tangible execution on its AI infrastructure plans, particularly the timelines associated with the OpenAI partnership. The company’s reiterated commitment is now under intense scrutiny. For Oracle, restoring market faith will require concrete delivery, not just promises.